P16 expression in squamous and trophoblastic lesions of the upper female genital tract

International Journal of Gynecological Pathology

Volumn 29, Issue 6, 2010, Pages 513-522

  Chew, Ivy ^a   Post, Miriam D ^c   Carinelli, Silvestro G ^e   Campbell, Sharon ^a   Di, Ye ^b   Soslow, Robert A ^d   Oliva, Esther ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Endometrioid adenocarcinoma with squamous differentiation; p16; Placental site nodule; Placental site trophoblastic tumor; Squamous cell carcinoma

Indexed keywords

PROTEIN P16; VIRUS DNA;

ADENOCARCINOMA; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; DNA DETERMINATION; ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA; FEMALE GENITAL TRACT CANCER; HUMAN; HUMAN CELL; ICHTHYOSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY CARCINOMA; OVARY TUMOR; POLYMERASE CHAIN REACTION; PRIMARY OVARIAN SQUAMOUS CELL CARCINOMA; PRIMARY UTERINE CORPUS SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TROPHOBLAST; TROPHOBLASTIC TUMOR; UTERUS CARCINOMA; VERRUCA VULGARIS; WART VIRUS;

DIAGNOSIS, DIFFERENTIAL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASMS, SQUAMOUS CELL; POLYMERASE CHAIN REACTION; TROPHOBLASTIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78149284057     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181e2fe70     Document Type: Article

References (82)

1. Koulos J, Symmans F, Chumas J, et al. Human papillomavirus detection in adenocarcinoma of the anus. Mod Pathol 1991; 4:58-61.
2. Dubina M, Goldenberg G. Viral-associated nonmelanoma skin cancers: a review. Am J Dermatopathol 2009;31:561-73.
3. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 2009;15:6758-62.
4. Galloway DA, McDougall JK. Human papillomaviruses and carcinomas. Adv Virus Res 1989;37:125-71.
5. Gissmann L, Boshart M, Durst M, et al. Presence of human papillomavirus in genital tumors. J Invest Dermatol 1984;83: 26s-8s.
6. Dionigi A, Oliva E, Clement PB, et al. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration: a clinicopathologic study of 50 cases. Am J Surg Pathol 2002;26:567-81.
7. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
8. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
9. Murphy N, Ring M, Killalea AG, et al. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears. J Clin Pathol 2003;56:56-63.
10. Milde-Langosch K, Riethdorf L, Bamberger AM, et al. P16/MTS1 and pRB expression in endometrial carcinomas. Virchows Arch 1999;434:23-8.
11. McCluggage WG, Jenkins D. p16 immunoreactivity may assist in the distinction between endometrial and endocervical adenocarcinoma. Int J Gynecol Pathol 2003;22:231-5.
12. Silverberg SG, Kurman RJ, Mutter GL, et al. Epithelial tumors and related lesions in tumors of the uterine corpus. In: Tavassoli FA, Devilee P. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003.
13. Ralston Howe E, Li Z, McGlennen RC, et al. Type-specific prevalence and persistence of human papillomavirus in women in the United States who are referred for typing as a component of cervical cancer screening. Am J Obstet Gynecol 2009;200:e241-7.
14. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
15. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
16. Cohen JA, Geradts J. Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas. Hum Pathol 1997;28:893-8.
17. Vo QN, Geradts J, Boudreau DA, et al. CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables. Hum Pathol 2002;33:1200-4.
18. Guenova M, Rassidakis GZ, Gorgoulis VG, et al. p16INK4A is regularly expressed in Hodgkin's disease: comparison with retinoblastoma, p53 and MDM2 protein status, and the presence of Epstein-Barr virus. Mod Pathol 1999;12:1062-71.
19. Bai M, Vlachonikolis J, Agnantis NJ, et al. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol 2001; 14:1105-13.
20. Beasley MB, Lantuejoul S, Abbondanzo S, et al. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum Pathol 2003;34:136-42.
21. Leversha MA, Fielding P, Watson S, et al. Expression of p53, pRB, and p16 in lung tumors: a validation study on tissue microarrays. J Pathol 2003;200:610-9.
22. Li Y, Nichols MA, Shay JW, et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994;54:6078-82.
23. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006;13:8-15.
24. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004;35:689-96.
25. Cameron RI, Maxwell P, Jenkins D, et al. Immunohistochem-ical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002;41:313-21.
26. Dray M, Russell P, Dalrymple C, et al. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: experience with squamous lesions in 189 consecutive cervical biopsies. Pathology 2005;37:112-24.
27. Yemelyanova A, Ji H, Shih IM, et al. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohis-tochemical analysis of 201 cases. Am J Surg Pathol 2009;33: 1504-14.
28. Milde-Langosch K, Riethdorf S, Kraus-Poppinghaus A, et al. Expression of cyclin-dependent kinase inhibitors p16 MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas. Virchows Arch 2001;439: 55-61.
29. Horn LC, Richter CE, Einenkel J, et al. p16, p14, p53, cyclin D1, and steroid hormone receptor expression and human papillomaviruses analysis in primary squamous cell carcinoma of the endometrium. Ann Diagn Pathol 2006;10:193-6.
30. Armes JE, Lourie R, de Silva M, et al. Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein. Int J Gynecol Pathol 2005;24:363-8.
31. Kommoss S, du Bois A, Ridder R, et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Br J Cancer 2007;96:306-13.
32. Fluhmann CF. Squamous epithelium in the endometrium in benign and malignant conditions. Surg Gynecol Obstet 1928;46:309-16.
33. Zidi YS, Bouraoui S, Atallah K, et al. Primary in situ squamous cell carcinoma of the endometrium, with extensive squamous metaplasia and dysplasia. Gynecol Oncol 2003;88: 444-6.
34. Rodolakis A, Papaspyrou I, Sotiropoulou M, et al. Primary squamous cell carcinoma of the endometrium. A report of 3 cases. Eur J Gynecol Oncol 2001;22:143-6.
35. Baggish MS, Woodruff JD. The occurrence of squamous epithelium in the endometrium. Obstet Gynecol Surv 1967;22:69-115.
36. Kondis A, Liapis A, Kairi E, et al. Primary squamous cell carcinoma of the endometrium. Immunopathological study of a case. Eur J Gynecol Oncol 1999;20:235-6.
37. Kataoka A, Nishida T, Sugiyama T, et al. Squamous cell carcinoma of the endometrium with human papillomavirus type 31 and without tumor suppressor gene p53 mutation. Gynecol Oncol 1997;65:180-4.
38. Im DD, Shah KV, Rosenshein NB. Report of three new cases of squamous carcinoma of the endometrium with emphasis in the HPV status. Gynecol Oncol 1995;56:464-9.
39. Giordano G, Azzoni C, D'Adda T, et al. P16(INK4a) overexpression independent of human papilloma virus (HPV) infection in rare subtypes of endometrial carcinomas. Pathol Res Pract 2007;203:533-8.
40. Bewtra C, Xie QM, Hunter WJ, et al. Ichthyosis uteri: a case report and review of the literature. Arch Pathol Lab Med 2005;129:e124-5.
41. Ansari-Lari MA, Staebler A, Zaino RJ, et al. Distinction of endocervical and endometrial adenocarcinomas: immunohis-tochemical p16 expression correlated with human papilloma-virus (HPV) DNA detection. Am J Surg Pathol 2004;28:160-7.
42. Reid-Nicholson M, Iyengar P, Hummer AJ, et al. Immunophe-notypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol 2006;19:1091-100.
43. Buza N, Tavassoli FA. Comparative analysis of P16 and P53 expression in uterine malignant mixed Mullerian tumors. Int J Gynecol Pathol 2009;28:514-21.
44. Chiesa-Vottero AG, Malpica A, Deavers MT, et al. Immuno-histochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Int J Gynecol Pathol 2007;26:328-33.
45. de Villiers EM, Schneider A, Gross G, et al. Analysis of benign and malignant urogenital tumors for human papillomavirus infection by labelling cellular DNA. Med Microbiol Immunol 1986;174:281-6.
46. Bergeron C, Shah K, Daniel R, et al. Search for human papillomaviruses in normal, hyperplastic, and neoplastic endometria. Obstet Gynecol 1988;72:383-7.
47. Tsunokawa Y, Takebe N, Nozawa S, et al. Presence of human papillomavirus type-16 and type-18 DNA sequences and their expression in cervical cancers and cell lines from Japanese patients. Int J Cancer 1986;37:499-503.
48. Czerwenka K, Lu Y, Heuss F, et al. Human papillomavirus detection of endometrioid carcinoma with squamous differentiation of the uterine corpus. Gynecol Oncol 1996;61: 210-4.
49. Yemelyanova A, Vang R, Seidman JD, et al. Endocervical adenocarcinomas with prominent endometrial or endomyome-trial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Am J Surg Pathol 2009; 33:914-24.
50. Kealy WF, Annis PG, Barry JA, et al. Adenoacanthoma of the endometrium: morphological changes induced by human papillomavirus. J Clin Pathol 1990;43:554-9.
51. Lai CH, Hsueh S, Lin CY, et al. Human papillomavirus in benign and malignant ovarian and endometrial tissues. Int J Gynecol Pathol 1992;11:210-5.
52. Milde-Langosch K, Becker G, Loning T. Human papilloma-virus and c-myc/c-erbB2 in uterine and vulvar lesions. Virchows Arch A Pathol Anat Histopathol 1991;419:479-85.
53. O'Leary JJ, Landers RJ, Crowley M, et al. Human papillo-mavirus and mixed epithelial tumors of the endometrium. Hum Pathol 1998;29:383-9.
54. Chinen K, Kamiyama K, Kinjo T, et al. Morules in endometrial carcinoma and benign endometrial lesions differ from squamous differentiation tissue and are not infected with human papillomavirus. J Clin Pathol 2004;57: 918-26.
55. Kinjo T, Kamiyama K, Chinen K, et al. Squamous metaplasia induced by transfection of human papillomavirus DNA into cultured adenocarcinoma cells. Mol Pathol 2003;56: 97-108.
56. Kashimura M, Shinohara M, Hirakawa T, et al. Clinicopatho-logic study of squamous cell carcinoma of the ovary. Gynecol Oncol 1989;34:75-9.
57. Tetu B, Silva EG, Gershenson DM. Squamous cell carcinoma of the ovary. Arch Pathol Lab Med 1987;111:864-6.
58. Idelson MG. Malignancy in Brenner tumor of the ovary, with comments on histogenesis and possible estrogen production. Obstet Gynecol Surv 1963;18:246-67.
59. Amerigo J, Nogales FF Jr, Fernandez-Sanz J, et al. Squamous cell neoplasms arising from ovarian benign cystic teratoma. Gynecol Oncol 1979;8:277-83.
60. Peterson WF. Malignant degeneration of benign cystic teratomas of the overy: a collective review of the literature. Obstet Gynecol Surv 1957;12:793-830.
61. Shingleton HM, Middleton FF, Gore H. Squamous cell carcinoma in the ovary. Am J Obstet Gynecol 1974;120:556-60.
62. Hirakawa T, Tsuneyoshi M, Enjoji M. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis. Am J Surg Pathol 1989;13:397-405.
63. Krumerman MS, Chung A. Squamous carcinoma arising in benign cystic teratoma of the ovary: a report of four cases and review of the literature. Cancer 1977;39:1237-42.
64. Mostoufizadeh M, Scully RE. Malignant tumors arising in endometriosis. Clin Obstet Gynecol 1980;23:951-63.
65. Pins MR, Young RH, Daly WJ, et al. Primary squamous cell carcinoma of the ovary. Report of 37 cases. Am J Surg Pathol 1996;20:823-33.
66. Chen KT. Squamous cell carcinoma of the ovary. Arch Pathol Lab Med 1988;112:114-5.
67. Young RH, Prat J, Scully RE. Epidermoid cyst of the ovary. A report of three cases with comments on histogenesis. Am J Clin Pathol 1980;73:272-6.
68. Sworn MJ, Jones H, Letchworth AT, et al. Squamous intraepithelial neoplasia in an ovarian cyst, cervical intra-epithelial neoplasia, and human papillomavirus. Hum Pathol 1995;26:344-7.
69. McGrady BJ, Sloan JM, Lamki H, et al. Bilateral ovarian cysts with squamous intraepithelial neoplasia. Int J Gynecol Pathol 1993;12:350-4.
70. Yetman TJ, Dudzinski MR. Primary squamous carcinoma of the ovary: a case report and review of the literature. Gynecol Oncol 1989;34:240-3.
71. Mai KT, Yazdi HM, Bertrand MA, et al. Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithe-lial neoplasia. A case report with review of the literature. Am J Surg Pathol 1996;20:767-72.
72. Pins MR, Young RH, Crum CP, et al. Cervical squamous cell carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papilloma virus analysis. Int J Gynecol Pathol 1997;16:272-8.
73. Young RH, Gersell DJ, Roth LM, et al. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. A report of 12 cases. Cancer 1993;71:407-18.
74. Genadry R, Parmley T, Woodruff JD. Simultaneous malignant squamous metaplasia of the cervix and ovary. Gynecol Oncol 1979;8:87-91.
75. Black WC, Benitez RE. Nonteratomatous squamous-cell carcinoma in situ of the ovary. Obstet Gynecol 1964;24:865-8.
76. Manolitsas TP, Lanham SA, Hitchcock A, et al. Synchronous ovarian and cervical squamous intraepithelial neoplasia: an analysis of HPV status. Gynecol Oncol 1998;70:428-31.
77. Vang R, Gown AM, Farinola M, et al. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Am J Surg Pathol 2007;31:653-63.
78. Wentzensen N, du Bois A, Kommoss S, et al. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group. Int J Gynecol Pathol 2008;27:18-23.
79. Phillips V, Kelly P, McCluggage WG. Increased p16 expression in high-grade serous and undifferentiated carcinoma compared with other morphologic types of ovarian carcinoma. Int J Gynecol Pathol 2009;28:179-86.
80. Cuatrecasas M, Catasus L, Palacios J, et al. Transitional cell tumors of the ovary: a comparative clinicopathologic, im-munohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas. Am J Surg Pathol 2009;33:556-67.
81. Mao TL, Seidman JD, Kurman RJ, et al. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor\an aid in differential diagnosis. Am J Surg Pathol 2006;30:1105-10.
82. Kalhor N, Ramirez PT, Deavers MT, et al. Immunohisto-chemical studies of trophoblastic tumors. Am J Surg Pathol 2009;33:633-8.